Recent News
Aug 8, 2025 — Enovis announced management will present at the Canaccord Genuity and Wells Fargo conferences and at the Baird Global Healthcare Conference in August–September 2025. Sept 8, 2025 — Company moved its scheduled Baird presentation time to 2:35 p.m. ET on Sept 10, 2025. These items focused on investor access and conference scheduling rather than operational disclosures.
Technical Analysis
ADX at 19.38 indicates no established trend; that reduces confidence in directional persistence and frames the near-term move as momentum-driven rather than trend-dominant, which aligns with a tactical valuation re-rating opportunity rather than a sustained breakout thesis.
Directional indicators show bullish bias: DI+ at 24.78 with a dip-and-reversal signals renewed upside pressure, and DI- at 16.07 decreasing, which also supports short-term bullish directional balance; both suggest constructive near-term price bias that could translate to a re-appraisal of valuation if sustained.
MACD reads 0.37, the MACD line rising and sitting above the signal line at 0.18; that cross-above confirms bullish momentum and aligns with the recent uptick in short-term moving averages, supporting the probability of additional upside probing in the coming weeks.
MRO at -7.33 with a dip-and-reversal places the price below the model target and signals upward adjustment potential; the negative MRO complements MACD’s bullish momentum while cautioning that the position sits below structural targets used in regression-based valuation.
RSI at 53.33 and rising remains in neutral-to-mildly-bullish territory; momentum shows room to run before overbought conditions appear, which supports the idea of measured gains rather than an immediate exhaustion.
Price sits above short-term averages (20-day $31.47, 50-day $31.20, 12-/26-day EMAs near $31.90/$31.48) but below the 200-day average of $34.62, implying short-term strength inside a longer-term resistance band; Ichimoku components (Tenkan $31.20, Kijun $31.43, SenkouA $30.90, SenkouB $31.14) lie below price and act as technical support, while the super trend lower at $30.45 provides an additional near-term support reference.
Bollinger positioning shows the share trading slightly above the 1x upper band ($32.64) and under the 2x upper band ($33.80), indicating contained volatility on an intramonth basis. Volume of 533,049 trails the 10-day average of 615,513 and the 50/200-day averages, suggesting current moves carry lighter-than-average conviction despite bullish indicator alignment.
Fundamental Analysis
Earnings and cash-flow profile present mixed signals. EPS came in at $0.79 versus an estimate of $0.72, representing an EPS surprise of 9.72%, which supports the narrative of operational improvement communicated to investors. Adjusted EBITDA at $55,191,000 contrasts with an operating loss: EBIT at -$16,360,000 produced an EBIT margin of -2.90% (QoQ change -66.37%; YoY improvement +46.59%). The negative operating margin sits below the industry peer mean of 18.50% and the industry peer median of 17.48%.
Revenue totaled $564,545,000. Reported gross margin of 59.29% sits slightly under the industry peer mean of 62.19% but demonstrates product-level profitability that feeds adjusted-EBITDA strength. WMDST notes operating leverage remains weak: operating margin sits negative while YoY operating-margin improvement registers +44.06%.
Cash generation shows operating cash flow of $47,769,000 and free cash flow of $3,400,000, producing a free cash flow yield of 0.19%, below the industry peer mean of 0.68%. Working-capital dynamics require attention: a cash-conversion cycle of 235.8 days exceeds the industry peer mean of 170.8 days, reflecting inventory and receivables duration that constrains cash conversion despite a current ratio of 2.25 and quick ratio of 1.15.
Leverage metrics present structural constraints: total debt $1,464,772,000 and net debt $1,349,465,000 produce debt-to-equity of 0.57 and a debt-to-EBITDA of 26.54, a level that magnifies interest and refinancing sensitivity; interest coverage remains negative. Asset efficiency shows asset turnover of 0.114, roughly in line with the industry peer mean of 0.121.
Valuation and WMDST view: WMDST values the stock as under-valued. Market multiples show a P/E of 39.4 and P/B of 0.68, both below their respective industry peer means (P/E peer mean ~136.7, P/B peer mean ~6.30), indicating the market currently prices a large discount relative to peer multiples while fundamentals show improving margins and modest cash generation that could support multiple expansion only if leverage and working-capital trends stabilize.
MOST-RECENT QUARTERLY REPORT
| REPORT PERIOD ENDING: | 2025-06-30 |
| REPORT DATE: | 2025-08-07 |
| NEXT REPORT DATE: | 2025-11-06 |
| CASH FLOW | Begin Period Cash Flow | $ 38.5 M |
| Operating Cash Flow | $ 47.8 M | |
| Capital Expenditures | $ -44.37 M | |
| Change In Working Capital | $ 2.8 M | |
| Dividends Paid | — | |
| Cash Flow Delta | $ 5.6 M | |
| End Period Cash Flow | $ 44.1 M | |
| INCOME STATEMENT | REVENUE | |
| Total Revenue | $ 564.5 M | |
| Forward Revenue | $ -173.47 M | |
| COSTS | ||
| Cost Of Revenue | $ 229.8 M | |
| Depreciation | $ 28.6 M | |
| Depreciation and Amortization | $ 71.6 M | |
| Research and Development | $ 30.7 M | |
| Total Operating Expenses | $ 580.6 M | |
| PROFITABILITY | ||
| Gross Profit | $ 334.7 M | |
| EBITDA | $ 55.2 M | |
| EBIT | $ -16.36 M | |
| Operating Income | $ -16.08 M | |
| Interest Income | — | |
| Interest Expense | $ 9.3 M | |
| Net Interest Income | $ -9.29 M | |
| Income Before Tax | $ -25.65 M | |
| Tax Provision | $ 10.8 M | |
| Tax Rate | 21.0 % | |
| Net Income | $ -36.74 M | |
| Net Income From Continuing Operations | $ -36.55 M | |
| EARNINGS | ||
| EPS Estimate | $ 0.72 | |
| EPS Actual | $ 0.79 | |
| EPS Difference | $ 0.07 | |
| EPS Surprise | 9.722 % | |
| Forward EPS | $ 0.79 | |
| BALANCE SHEET | ASSETS | |
| Total Assets | $ 5.0 B | |
| Intangible Assets | $ 3.1 B | |
| Net Tangible Assets | $ -545.13 M | |
| Total Current Assets | $ 1.3 B | |
| Cash and Short-Term Investments | $ 44.1 M | |
| Cash | $ 44.1 M | |
| Net Receivables | $ 453.7 M | |
| Inventory | $ 628.2 M | |
| Long-Term Investments | $ 92.4 M | |
| LIABILITIES | ||
| Accounts Payable | $ 212.0 M | |
| Short-Term Debt | $ 20.0 M | |
| Total Current Liabilities | $ 568.2 M | |
| Net Debt | $ 1.3 B | |
| Total Debt | $ 1.5 B | |
| Total Liabilities | $ 2.4 B | |
| EQUITY | ||
| Total Equity | $ 2.6 B | |
| Retained Earnings | $ -375.73 M | |
| VALUATION & PER-SHARE METRICS | EQUITY & PER-SHARE METRICS | |
| Book Value Per-Share | $ 45.11 | |
| Shares Outstanding | 57.159 M | |
| Revenue Per-Share | $ 9.88 | |
| VALUATION | Market Capitalization | $ 1.8 B |
| Enterprise Value | $ 3.2 B | |
| Enterprise Multiple | 57.493 | |
| Enterprise Multiple QoQ | -62.177 % | |
| Enterprise Multiple YoY | 22.333 % | |
| Enterprise Multiple IPRWA | high: 123.29 median: 110.415 mean: 94.091 ENOV: 57.493 low: -147.649 |
|
| EV/R | 5.621 | |
| CAPITAL STRUCTURE | ||
| Asset To Equity | 1.948 | |
| Asset To Liability | 2.058 | |
| Debt To Capital | 0.362 | |
| Debt To Assets | 0.292 | |
| Debt To Assets QoQ | -2.52 % | |
| Debt To Assets YoY | 10469.203 % | |
| Debt To Assets IPRWA | high: 0.843 mean: 0.299 ENOV: 0.292 median: 0.289 low: 0.0 |
|
| Debt To Equity | 0.568 | |
| Debt To Equity QoQ | 1.947 % | |
| Debt To Equity YoY | 12331.947 % | |
| Debt To Equity IPRWA | high: 3.369 mean: 0.631 median: 0.579 ENOV: 0.568 low: -0.395 |
|
| PRICE-BASED VALUATION | ||
| Price To Book (P/B) | 0.68 | |
| Price To Book QoQ | -15.967 % | |
| Price To Book YoY | -14.828 % | |
| Price To Book IPRWA | high: 16.759 median: 6.869 mean: 6.298 ENOV: 0.68 low: -5.981 |
|
| Price To Earnings (P/E) | 39.409 | |
| Price To Earnings QoQ | -13.889 % | |
| Price To Earnings YoY | -48.885 % | |
| Price To Earnings IPRWA | high: 249.6 mean: 136.722 median: 121.658 ENOV: 39.409 low: -167.592 |
|
| PE/G Ratio | -0.218 | |
| Price To Sales (P/S) | 3.104 | |
| Price To Sales QoQ | -18.074 % | |
| Price To Sales YoY | -37.844 % | |
| Price To Sales IPRWA | high: 73.117 mean: 32.489 median: 24.499 ENOV: 3.104 low: 0.6 |
|
| FORWARD MULTIPLES | ||
| Forward P/E | 42.919 | |
| Forward PE/G | -0.238 | |
| Forward P/S | -10.102 | |
| EFFICIENCY | OPERATIONAL | |
| Operating Leverage | -64.612 | |
| ASSET & SALES | ||
| Asset Turnover Ratio | 0.114 | |
| Asset Turnover Ratio QoQ | -2.069 % | |
| Asset Turnover Ratio YoY | 18.621 % | |
| Asset Turnover Ratio IPRWA | high: 0.412 median: 0.124 mean: 0.121 ENOV: 0.114 low: 0.008 |
|
| Receivables Turnover | 1.27 | |
| Receivables Turnover Ratio QoQ | -4.279 % | |
| Receivables Turnover Ratio YoY | -6.224 % | |
| Receivables Turnover Ratio IPRWA | high: 3.133 mean: 1.736 median: 1.672 ENOV: 1.27 low: 0.374 |
|
| Inventory Turnover | 0.379 | |
| Inventory Turnover Ratio QoQ | -5.345 % | |
| Inventory Turnover Ratio YoY | -3.769 % | |
| Inventory Turnover Ratio IPRWA | high: 2.014 mean: 0.649 median: 0.568 ENOV: 0.379 low: 0.084 |
|
| Days Sales Outstanding (DSO) | 71.872 | |
| CASH CYCLE | ||
| Cash Conversion Cycle Days (CCC) | 235.757 | |
| Cash Conversion Cycle Days QoQ | 14.087 % | |
| Cash Conversion Cycle Days YoY | -6.595 % | |
| Cash Conversion Cycle Days IPRWA | high: 448.876 ENOV: 235.757 mean: 170.833 median: 167.784 low: -175.55 |
|
| CAPITAL DEPLOYMENT | ||
| Cash Conversion Ratio | 0.793 | |
| CapEx To Revenue | -0.079 | |
| CapEx To Depreciation | -1.552 | |
| CAPITAL, LIQUIDITY & COVERAGE | CAPITAL STRUCTURE | |
| Total Capital | $ 4.0 B | |
| Net Invested Capital | $ 4.0 B | |
| Invested Capital | $ 4.0 B | |
| Net Tangible Assets | $ -545.13 M | |
| Net Working Capital | $ 712.2 M | |
| LIQUIDITY | ||
| Cash Ratio | 0.078 | |
| Current Ratio | 2.253 | |
| Current Ratio QoQ | -11.686 % | |
| Current Ratio YoY | -0.467 % | |
| Current Ratio IPRWA | high: 19.146 mean: 2.55 ENOV: 2.253 median: 1.718 low: 0.027 |
|
| Quick Ratio | 1.148 | |
| Quick Ratio QoQ | -13.334 % | |
| Quick Ratio YoY | 6.603 % | |
| Quick Ratio IPRWA | high: 12.697 mean: 1.882 median: 1.167 ENOV: 1.148 low: 0.315 |
|
| COVERAGE & LEVERAGE | ||
| Debt To EBITDA | 26.54 | |
| Cost Of Debt | 0.502 % | |
| Interest Coverage Ratio | -1.76 | |
| Interest Coverage Ratio QoQ | -66.418 % | |
| Interest Coverage Ratio YoY | 187.684 % | |
| Interest Coverage Ratio IPRWA | high: 52.298 mean: 15.493 median: 11.456 ENOV: -1.76 low: -88.481 |
|
| Operating Cash Flow Ratio | -0.003 | |
| TIMING / LIQUIDITY | ||
| Days Payables Outstanding (DPO) | 80.57 | |
| DIVIDENDS | ||
| Dividend Coverage Ratio | — | |
| Dividend Payout Ratio | — | |
| Dividend Rate | — | |
| Dividend Yield | — | |
| PERFORMANCE | GROWTH | |
| Asset Growth Rate | 3.002 % | |
| Revenue Growth | 1.022 % | |
| Revenue Growth QoQ | -367.539 % | |
| Revenue Growth YoY | -40.685 % | |
| Revenue Growth IPRWA | high: 26.158 % median: 8.281 % mean: 6.326 % ENOV: 1.022 % low: -39.052 % |
|
| Earnings Growth | -180.612 % | |
| Earnings Growth QoQ | 941.171 % | |
| Earnings Growth YoY | -852.55 % | |
| Earnings Growth IPRWA | high: 103.125 % mean: 10.977 % median: 9.851 % low: -164.885 % ENOV: -180.612 % |
|
| MARGINS | ||
| Gross Margin | 59.286 % | |
| Gross Margin QoQ | -0.276 % | |
| Gross Margin YoY | 7.775 % | |
| Gross Margin IPRWA | high: 91.006 % median: 63.683 % mean: 62.192 % ENOV: 59.286 % low: -7.085 % |
|
| EBIT Margin | -2.898 % | |
| EBIT Margin QoQ | -66.373 % | |
| EBIT Margin YoY | 46.586 % | |
| EBIT Margin IPRWA | high: 33.709 % mean: 18.504 % median: 17.478 % ENOV: -2.898 % low: -200.872 % |
|
| Return On Sales (ROS) | -2.848 % | |
| Return On Sales QoQ | -66.953 % | |
| Return On Sales YoY | 44.057 % | |
| Return On Sales IPRWA | high: 39.857 % mean: 18.91 % median: 18.374 % ENOV: -2.848 % low: -215.416 % |
|
| CASH FLOW | ||
| Free Cash Flow (FCF) | $ 3.4 M | |
| Free Cash Flow Yield | 0.194 % | |
| Free Cash Flow Yield QoQ | -109.155 % | |
| Free Cash Flow Yield YoY | -116.086 % | |
| Free Cash Flow Yield IPRWA | high: 4.685 % median: 0.712 % mean: 0.677 % ENOV: 0.194 % low: -19.501 % |
|
| Free Cash Growth | -107.579 % | |
| Free Cash Growth QoQ | -52.746 % | |
| Free Cash Growth YoY | 89.673 % | |
| Free Cash Growth IPRWA | high: 310.383 % mean: 85.94 % median: 14.619 % ENOV: -107.579 % low: -376.098 % |
|
| Free Cash To Net Income | -0.093 | |
| Cash Flow Margin | -0.303 % | |
| Cash Flow To Earnings | 0.047 | |
| VALUE & RETURNS | ||
| Economic Value Added | $ 0.02 | |
| Return On Assets (ROA) | -0.742 % | |
| Return On Assets QoQ | -36.418 % | |
| Return On Assets YoY | 117.595 % | |
| Return On Assets IPRWA | high: 16.404 % mean: 1.746 % median: 1.686 % ENOV: -0.742 % low: -35.697 % |
|
| Return On Capital Employed (ROCE) | -0.367 % | |
| Return On Equity (ROE) | -0.014 | |
| Return On Equity QoQ | -33.349 % | |
| Return On Equity YoY | 151.323 % | |
| Return On Equity IPRWA | high: 0.175 median: 0.032 mean: 0.029 ENOV: -0.014 low: -0.524 |
|
| DuPont ROE | -1.414 % | |
| Return On Invested Capital (ROIC) | -0.325 % | |
| Return On Invested Capital QoQ | -72.103 % | |
| Return On Invested Capital YoY | -100.928 % | |
| Return On Invested Capital IPRWA | high: 5.672 % median: 2.571 % mean: 2.227 % ENOV: -0.325 % low: -19.888 % |
|